Literature DB >> 16982845

Role for matrix metalloproteinase 9 in granuloma formation during pulmonary Mycobacterium tuberculosis infection.

Jennifer L Taylor1, Jessica M Hattle, Steven A Dreitz, JoLynn M Troudt, Linda S Izzo, Randall J Basaraba, Ian M Orme, Lynn M Matrisian, Angelo A Izzo.   

Abstract

Recent studies have shown that matrix metalloproteinases (MMPs) are induced by Mycobacterium tuberculosis during pulmonary infection. Here, expression of MMP-9 during pulmonary M. tuberculosis infection was characterized to determine whether its production correlated with disease resistance in vivo and to determine what role, if any, MMP-9 might have in granuloma formation. Following aerosol infection with M. tuberculosis, dissemination of bacilli occurred earlier in the C57BL/6 resistant mouse strain than in the susceptible CBA/J strain, as was evident from an increased number of bacteria in the blood, spleen, and liver at day 14 after infection. In addition, early dissemination of the bacilli was associated with early induction of protective immunity as assessed from gamma interferon levels. Nonspecific blocking of MMPs in C57BL/6 mice early during infection reduced hematogenous spread of the bacilli, suggesting that MMPs indeed play a role in facilitating dissemination, likely via extracellular matrix degradation. The concentration of active MMP-9, specifically, was greater in the lungs of C57BL/6 mice than in those of the CBA/J mice at day 28, thereby suggesting that MMP-9 is not one of the MMPs directly involved in promoting early dissemination of M. tuberculosis. Instead, however, histological lung sections and flow cytometric analysis of lung cells from MMP-9-knockout mice showed that MMP-9 is involved in macrophage recruitment and granuloma development. These combined data support the idea that early MMP activity is an essential component of resistance to pulmonary mycobacterial infection and that MMP-9, specifically, is required for recruitment of macrophages and tissue remodeling to allow for the formation of tight, well-organized granulomas.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16982845      PMCID: PMC1695484          DOI: 10.1128/IAI.02048-05

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  44 in total

Review 1.  Matrix metalloproteinases as modulators of inflammation and innate immunity.

Authors:  William C Parks; Carole L Wilson; Yolanda S López-Boado
Journal:  Nat Rev Immunol       Date:  2004-08       Impact factor: 53.106

2.  Identification of a matrix-degrading phenotype in human tuberculosis in vitro and in vivo.

Authors:  N M Price; J Farrar; T T Tran; T H Nguyen; T H Tran; J S Friedland
Journal:  J Immunol       Date:  2001-03-15       Impact factor: 5.422

3.  Decreased allergic lung inflammatory cell egression and increased susceptibility to asphyxiation in MMP2-deficiency.

Authors:  David B Corry; Kirtee Rishi; John Kanellis; Attila Kiss; Li-zhen Song Lz; Jie Xu; Lili Feng; Zena Werb; Farrah Kheradmand
Journal:  Nat Immunol       Date:  2002-03-11       Impact factor: 25.606

Review 4.  Gelatinase B functions as regulator and effector in leukocyte biology.

Authors:  G Opdenakker; P E Van den Steen; B Dubois; I Nelissen; E Van Coillie; S Masure; P Proost; J Van Damme
Journal:  J Leukoc Biol       Date:  2001-06       Impact factor: 4.962

5.  Occurrence of matrix metalloproteinases and tissue inhibitors of metalloproteinases in tuberculous pleuritis.

Authors:  G Hoheisel; U Sack; D S Hui; K Huse; K S Chan; K K Chan; K Hartwig; E Schuster; G H Scholz; J Schauer
Journal:  Tuberculosis (Edinb)       Date:  2001       Impact factor: 3.131

6.  Immunological basis for reactivation of tuberculosis in mice.

Authors:  J Turner; M Gonzalez-Juarrero; B M Saunders; J V Brooks; P Marietta; D L Ellis; A A Frank; A M Cooper; I M Orme
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

7.  Marked increase of matrix metalloproteinase 9 in cerebrospinal fluid of patients with fungal or tuberculous meningoencephalitis.

Authors:  E Matsuura; F Umehara; T Hashiguchi; N Fujimoto; Y Okada; M Osame
Journal:  J Neurol Sci       Date:  2000-02-01       Impact factor: 3.181

8.  Production of matrix metalloproteinases in response to mycobacterial infection.

Authors:  M Quiding-Järbrink; D A Smith; G J Bancroft
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

9.  Temporal and spatial arrangement of lymphocytes within lung granulomas induced by aerosol infection with Mycobacterium tuberculosis.

Authors:  M Gonzalez-Juarrero; O C Turner; J Turner; P Marietta; J V Brooks; I M Orme
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

Review 10.  Matrix metalloproteinases in lung biology.

Authors:  W C Parks; S D Shapiro
Journal:  Respir Res       Date:  2000-12-29
View more
  77 in total

1.  The Mycobacterium tuberculosis stress response factor SigH is required for bacterial burden as well as immunopathology in primate lungs.

Authors:  Smriti Mehra; Nadia A Golden; Kerstan Stuckey; Peter J Didier; Lara A Doyle; Kasi E Russell-Lodrigue; Chie Sugimoto; Atsuhiko Hasegawa; Satheesh K Sivasubramani; Chad J Roy; Xavier Alvarez; Marcelo J Kuroda; James L Blanchard; Andrew A Lackner; Deepak Kaushal
Journal:  J Infect Dis       Date:  2012-03-07       Impact factor: 5.226

2.  MMPs in tuberculosis: granuloma creators and tissue destroyers.

Authors:  Padmini Salgame
Journal:  J Clin Invest       Date:  2011-04-25       Impact factor: 14.808

3.  Zebrafishing for tuberculosis infection.

Authors:  Liwei Wang
Journal:  Protein Cell       Date:  2010-04       Impact factor: 14.870

4.  Matrix metalloproteinase proteolysis of the mycobacterial HSP65 protein as a potential source of immunogenic peptides in human tuberculosis.

Authors:  Sergey A Shiryaev; Piotr Cieplak; Alexander E Aleshin; Qing Sun; Wenhong Zhu; Khatereh Motamedchaboki; Alexander Sloutsky; Alex Y Strongin
Journal:  FEBS J       Date:  2011-08-08       Impact factor: 5.542

5.  Lack of alpha-1 integrin alters lesion morphology during pulmonary Mycobacterium tuberculosis infection.

Authors:  Jennifer L Taylor; Helle Bielefeldt-Ohmann; Ambra Pozzi; Angelo A Izzo
Journal:  Tuberculosis (Edinb)       Date:  2008-07-18       Impact factor: 3.131

Review 6.  Host-directed therapeutics for tuberculosis: can we harness the host?

Authors:  Thomas R Hawn; Alastair I Matheson; Stephen N Maley; Omar Vandal
Journal:  Microbiol Mol Biol Rev       Date:  2013-12       Impact factor: 11.056

7.  Tuberculous granuloma induction via interaction of a bacterial secreted protein with host epithelium.

Authors:  Hannah E Volkman; Tamara C Pozos; John Zheng; J Muse Davis; John F Rawls; Lalita Ramakrishnan
Journal:  Science       Date:  2009-12-10       Impact factor: 47.728

8.  PIM2 Induced COX-2 and MMP-9 expression in macrophages requires PI3K and Notch1 signaling.

Authors:  Kushagra Bansal; Nisha Kapoor; Yeddula Narayana; Germain Puzo; Martine Gilleron; Kithiganahalli Narayanaswamy Balaji
Journal:  PLoS One       Date:  2009-03-17       Impact factor: 3.240

9.  Dexamethasone, cerebrospinal fluid matrix metalloproteinase concentrations and clinical outcomes in tuberculous meningitis.

Authors:  Justin A Green; Chau T H Tran; Jeremy J Farrar; Mai T H Nguyen; Phu H Nguyen; Sinh X Dinh; Nghia D T Ho; Chuong V Ly; Hien T Tran; Jon S Friedland; Guy E Thwaites
Journal:  PLoS One       Date:  2009-09-30       Impact factor: 3.240

10.  An improved empirical bayes approach to estimating differential gene expression in microarray time-course data: BETR (Bayesian Estimation of Temporal Regulation).

Authors:  Martin J Aryee; José A Gutiérrez-Pabello; Igor Kramnik; Tapabrata Maiti; John Quackenbush
Journal:  BMC Bioinformatics       Date:  2009-12-10       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.